focus -WSS

focus

author：explore 2025-10-01 12:14:25 Page View：747

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： An inside look at PIPEs, biotech's buzzy new financing tool
Next article： In age of alternative facts, a scholarly course on calling out crap

explore

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

BoxesofmifepristoneAllenG.Breed/APThedrugstorechainsCVSHealthandWalgreensplantostartdispensingan abo

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

FILE-MembersgroupbearinginsigniasofthewhitesupremacistPatriotFrontshoveCharlesMurrellwithmetalshield